Clinical Trial Update: Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma

View source ↗

Summary

Clinical trial to integrate molecular and clinical profiling of splenic marginal zone lymphoma (transformed form), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Splenic Marginal Zone Lymphoma

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Transformed Splenic Marginal Zone Lymphoma | Status: RECRUITING